MET and colorectal carcinoma: We also identified all the altered and unaltered genes associated with c-Met/GSK3β/MYC/CCND1 signatures (Figure 6G) and further determined the distributions of c-Met/GSK3β/MYC/CCND1 mutations in CRC across the protein domains (Figure 6H–J).